Role of insulin receptor substrates in the progression of hepatocellular carcinoma

Yoshitaka Sakurai, Naoto Kubota, Iseki Takamoto, Atsushi Obata, Masahiko Iwamoto, Takanori Hayashi, Masakazu Aihara, Tetsuya Kubota, Hiroshi Nishihara, Takashi Kadowaki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Several cellular signaling pathways, including insulin/IGF signaling, are known to be activated in hepatocellular carcinoma (HCC). Here, we investigated the roles of insulin receptor substrate (Irs) 1 and Irs2, both of which are the major molecules to be responsible for transducing insulin/IGF signaling in the liver, in the development of HCC by inducing chemical carcinogenesis using diethylnitrosamine (DEN) in mice. The Irs1 mRNA and protein expressions were upregulated in the tumors, along with enhanced insulin signaling. Liver-specific Irs1-knockout (LIrs1KO) mice exhibited suppression of DEN-induced HCC development, accompanied by reduced cancer cell proliferative activity and reduced activation of Akt. Gene expression analyses revealed that the tumors in the DEN-treated LIrs1KO mice showed modest metabolic alterations during hepatocarcinogenesis as well as decreased inflammation and invasion potentials. On the other hand, liver-specific Irs2-knockout (LIrs2KO) mice showed a similar pattern of HCC development to the DEN-treated control wild-type mice. Based on the knowledge that Wnt/β-catenin signaling is activated in HCC, we focused on Wnt/β-catenin signaling and demonstrated that Irs1 expression was induced by Wnt3a stimulation in the primary hepatocytes, associated with insulin-stimulated Akt activation. These data suggest that upregulated Irs1 by Wnt/β-catenin signaling plays a crucial role in the progression of HCC.

Original languageEnglish
Article number5387
JournalScientific reports
Volume7
Issue number1
DOIs
Publication statusPublished - 2017 Dec 1
Externally publishedYes

Fingerprint

Insulin Receptor
Diethylnitrosamine
Hepatocellular Carcinoma
Catenins
Knockout Mice
Insulin
Liver
Insulin Receptor Substrate Proteins
Neoplasms
Hepatocytes
Carcinogenesis
Inflammation
Gene Expression
Messenger RNA
Proteins

ASJC Scopus subject areas

  • General

Cite this

Sakurai, Y., Kubota, N., Takamoto, I., Obata, A., Iwamoto, M., Hayashi, T., ... Kadowaki, T. (2017). Role of insulin receptor substrates in the progression of hepatocellular carcinoma. Scientific reports, 7(1), [5387]. https://doi.org/10.1038/s41598-017-03299-3

Role of insulin receptor substrates in the progression of hepatocellular carcinoma. / Sakurai, Yoshitaka; Kubota, Naoto; Takamoto, Iseki; Obata, Atsushi; Iwamoto, Masahiko; Hayashi, Takanori; Aihara, Masakazu; Kubota, Tetsuya; Nishihara, Hiroshi; Kadowaki, Takashi.

In: Scientific reports, Vol. 7, No. 1, 5387, 01.12.2017.

Research output: Contribution to journalArticle

Sakurai, Y, Kubota, N, Takamoto, I, Obata, A, Iwamoto, M, Hayashi, T, Aihara, M, Kubota, T, Nishihara, H & Kadowaki, T 2017, 'Role of insulin receptor substrates in the progression of hepatocellular carcinoma', Scientific reports, vol. 7, no. 1, 5387. https://doi.org/10.1038/s41598-017-03299-3
Sakurai Y, Kubota N, Takamoto I, Obata A, Iwamoto M, Hayashi T et al. Role of insulin receptor substrates in the progression of hepatocellular carcinoma. Scientific reports. 2017 Dec 1;7(1). 5387. https://doi.org/10.1038/s41598-017-03299-3
Sakurai, Yoshitaka ; Kubota, Naoto ; Takamoto, Iseki ; Obata, Atsushi ; Iwamoto, Masahiko ; Hayashi, Takanori ; Aihara, Masakazu ; Kubota, Tetsuya ; Nishihara, Hiroshi ; Kadowaki, Takashi. / Role of insulin receptor substrates in the progression of hepatocellular carcinoma. In: Scientific reports. 2017 ; Vol. 7, No. 1.
@article{e3d3893bf3744c2a86c2c83ea7f930c2,
title = "Role of insulin receptor substrates in the progression of hepatocellular carcinoma",
abstract = "Several cellular signaling pathways, including insulin/IGF signaling, are known to be activated in hepatocellular carcinoma (HCC). Here, we investigated the roles of insulin receptor substrate (Irs) 1 and Irs2, both of which are the major molecules to be responsible for transducing insulin/IGF signaling in the liver, in the development of HCC by inducing chemical carcinogenesis using diethylnitrosamine (DEN) in mice. The Irs1 mRNA and protein expressions were upregulated in the tumors, along with enhanced insulin signaling. Liver-specific Irs1-knockout (LIrs1KO) mice exhibited suppression of DEN-induced HCC development, accompanied by reduced cancer cell proliferative activity and reduced activation of Akt. Gene expression analyses revealed that the tumors in the DEN-treated LIrs1KO mice showed modest metabolic alterations during hepatocarcinogenesis as well as decreased inflammation and invasion potentials. On the other hand, liver-specific Irs2-knockout (LIrs2KO) mice showed a similar pattern of HCC development to the DEN-treated control wild-type mice. Based on the knowledge that Wnt/β-catenin signaling is activated in HCC, we focused on Wnt/β-catenin signaling and demonstrated that Irs1 expression was induced by Wnt3a stimulation in the primary hepatocytes, associated with insulin-stimulated Akt activation. These data suggest that upregulated Irs1 by Wnt/β-catenin signaling plays a crucial role in the progression of HCC.",
author = "Yoshitaka Sakurai and Naoto Kubota and Iseki Takamoto and Atsushi Obata and Masahiko Iwamoto and Takanori Hayashi and Masakazu Aihara and Tetsuya Kubota and Hiroshi Nishihara and Takashi Kadowaki",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-03299-3",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Role of insulin receptor substrates in the progression of hepatocellular carcinoma

AU - Sakurai, Yoshitaka

AU - Kubota, Naoto

AU - Takamoto, Iseki

AU - Obata, Atsushi

AU - Iwamoto, Masahiko

AU - Hayashi, Takanori

AU - Aihara, Masakazu

AU - Kubota, Tetsuya

AU - Nishihara, Hiroshi

AU - Kadowaki, Takashi

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Several cellular signaling pathways, including insulin/IGF signaling, are known to be activated in hepatocellular carcinoma (HCC). Here, we investigated the roles of insulin receptor substrate (Irs) 1 and Irs2, both of which are the major molecules to be responsible for transducing insulin/IGF signaling in the liver, in the development of HCC by inducing chemical carcinogenesis using diethylnitrosamine (DEN) in mice. The Irs1 mRNA and protein expressions were upregulated in the tumors, along with enhanced insulin signaling. Liver-specific Irs1-knockout (LIrs1KO) mice exhibited suppression of DEN-induced HCC development, accompanied by reduced cancer cell proliferative activity and reduced activation of Akt. Gene expression analyses revealed that the tumors in the DEN-treated LIrs1KO mice showed modest metabolic alterations during hepatocarcinogenesis as well as decreased inflammation and invasion potentials. On the other hand, liver-specific Irs2-knockout (LIrs2KO) mice showed a similar pattern of HCC development to the DEN-treated control wild-type mice. Based on the knowledge that Wnt/β-catenin signaling is activated in HCC, we focused on Wnt/β-catenin signaling and demonstrated that Irs1 expression was induced by Wnt3a stimulation in the primary hepatocytes, associated with insulin-stimulated Akt activation. These data suggest that upregulated Irs1 by Wnt/β-catenin signaling plays a crucial role in the progression of HCC.

AB - Several cellular signaling pathways, including insulin/IGF signaling, are known to be activated in hepatocellular carcinoma (HCC). Here, we investigated the roles of insulin receptor substrate (Irs) 1 and Irs2, both of which are the major molecules to be responsible for transducing insulin/IGF signaling in the liver, in the development of HCC by inducing chemical carcinogenesis using diethylnitrosamine (DEN) in mice. The Irs1 mRNA and protein expressions were upregulated in the tumors, along with enhanced insulin signaling. Liver-specific Irs1-knockout (LIrs1KO) mice exhibited suppression of DEN-induced HCC development, accompanied by reduced cancer cell proliferative activity and reduced activation of Akt. Gene expression analyses revealed that the tumors in the DEN-treated LIrs1KO mice showed modest metabolic alterations during hepatocarcinogenesis as well as decreased inflammation and invasion potentials. On the other hand, liver-specific Irs2-knockout (LIrs2KO) mice showed a similar pattern of HCC development to the DEN-treated control wild-type mice. Based on the knowledge that Wnt/β-catenin signaling is activated in HCC, we focused on Wnt/β-catenin signaling and demonstrated that Irs1 expression was induced by Wnt3a stimulation in the primary hepatocytes, associated with insulin-stimulated Akt activation. These data suggest that upregulated Irs1 by Wnt/β-catenin signaling plays a crucial role in the progression of HCC.

UR - http://www.scopus.com/inward/record.url?scp=85024405596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024405596&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-03299-3

DO - 10.1038/s41598-017-03299-3

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 5387

ER -